Abstract
Phenylketonuria (PKU) is caused by variants in the phenylalanine hydroxylase (PAH) gene. We systematically investigated all 13 exons of the PAH gene and their flanking introns in 31 unrelated patients and their parents using next-generation sequencing (NGS). A total of 33 different variants were identified in 58 of 62 mutant PAH alleles. The prevalent variants with a relative frequency of 5 % or more were c.721C > T, c.1068C > A, c.611A > G, c.1197A > T, c.728G > A, c.331C > T, and c.442-1G > A. One novel variant was identified in this study—c.699C > G. We studied genotype–phenotype correlations using the Guldberg arbitrary value (AV) system, which revealed a consistency rate of 38 % (8/21) among the 21 predicted phenotypes. The genotype-based prediction of BH4 responsiveness was also evaluated, and 14 patients (45.2 %) were predicted to be BH4 responsive.
Conclusion: This study presents the spectrum of PAH variants in Jiangsu province. The information obtained from the genotype-based prediction of BH4 responsiveness might be used for the rational selection of candidates for BH4 testing.
What is known: |
• Phenylketonuria (PKU) is caused by variants in the phenylalanine hydroxylase (PAH) gene. • The spectrum of PAH variants in different Chinese populations has been reported. |
What is new: |
• This is the first report on the spectrum of PAH variants in Jiangsu province. • This study identified one novel PAH variant—c.699C>G—and and tries to show a genotype–phenotype relationship also regarding BH4-responsiveness. |
Similar content being viewed by others
Abbreviations
- PAH:
-
Phenylalanine hydroxylase
- PKU:
-
Phenylketonuria
References
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249
Blau N, Shen N, Carducci C (2014) Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn 14(6):655–671
Blau N, Yue WW, Perez B. Phenylalanine hydroxylase gene locus-specific database. http://www.biopku.org/home/pah.asp
Blau N, Yue WW, Perez B. BIOPKUdb: database of patients and genotypes causing HPA/PKU incl. BH4-responsive phenotype. http://www.biopku.org/home/biopku.asp
Groselj U, Tansek MZ, Kovac J, Hovnik T, Podkrajsek KT, Battelino T (2012) Five novel mutations and two large deletions in a population analysis of the phenylalanine hydroxylase gene. Mol Genet Metab 106(2):142–148
Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A, Mollica F, Meli C, Giovannini M, Riva E, Biasuccl G, Henriksen KF, Güttler F (1993) Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet 2(10):1703–1707
Guldberg P, Rey F, Zschocke J, Romano V, François B, Michiels L, Ullrich K, Hoffmann GF, Burgard P, Schmidt H, Meli C, Riva E, Dianzani I, Ponzone A, Rey J, Güttler F (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63(1):71–79
Karacić I, Meili D, Sarnavka V, Heintz C, Thöny B, Ramadza DP, Fumić K, Mardesić D, Barić I, Blau N (2009) Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency. Mol Genet Metab 97(3):165–171
Karam PE, Alhamra RS, Nemer G, Usta J (2013) Spectrum of mutations in Lebanese patients with phenylalanine hydroxylase deficiency. Gene 515(1):117–122
Polak E, Ficek A, Radvanszky J, Soltysova A, Urge O, Cmelova E, Kantarska D, Kadasi L (2013) Phenylalanine hydroxylase deficiency in the Slovak population: genotype-phenotype correlations and genotype-based predictions of BH4-responsiveness. Gene 526(2):347–355
Report of birth defects prevention in China (2012) Ministry of Health of the People’s Republic of China http://www.gov.cn/gzdt/2012-09/12/content_2223371.htm
Song F, Qu YJ, Zhang T, Jin YW, Wang H, Zheng XY (2005) Phenylketonuria mutations in Northern China. Mol Genet Metab 86(Suppl 1):S107–S118
Trunzo R, Santacroce R, D'Andrea G, Longo V, De Girolamo G, Dimatteo C, Leccese A, Lillo V, Papadia F, Margaglione M (2013) Mutation analysis in hyperphenylalaninemia patients from South Italy. Clin Biochem 46(18):1896–1898
Vela-Amieva M, Abreu-González M, González-Del Angel A, Ibarra-González I, Fernández-Lainez C, Barrientos-Ríos R, Monroy-Santoyo S, Guillén-López S, Alcántara-Ortigoza MA (2014) Phenylalanine hydroxylase deficiency in Mexico: genotype-phenotype correlations, BH4 responsiveness and evidence of a founder effect. Clin Genet. doi:10.1111/cge.12444
Yu WZ, Qiu DH, Song F, Liu L, Liu SM, Jin YW, Zhang YL, Zou HY, He J, Lei Q, Liu XW (2008) Mutation characteristics of the PAH gene in four nationality groups in Xinjiang of China. J Genet 87(3):293–297
Zekanowski C, Nowacka M, Radomyska B, Cabalska B (2001) Should newborn mutation scanning for hyperphenylalaninaemia and galactosaemia be implemented? A Polish experience. J Med Screen 8(3):132–136
Zhou YA, Ma YX, Zhang QB, Gao WH, Liu JP, Yang JP, Zhang GX, Zhang XG, Yu L (2012) Mutations of the phenylalanine hydroxylase gene in patients with phenylketonuria in Shanxi, China. Genet Mol Biol 35(4):709–713
Zhu T, Qin S, Ye J, Qiu W, Han L, Zhang Y, Gu X (2010) Mutational spectrum of phenylketonuria in the Chinese Han population: a novel insight into the geographic distribution of the common mutations. Pediatr Res 67(3):280–285
Zhu T, Ye J, Han L, Qiu W, Zhang H, Liang L, Gu X (2013) Variations in genotype-phenotype correlations in phenylalanine hydroxylase deficiency in Chinese Han population. Gene 529(1):80–87
Zschocke J, Hoffmann GF (1999) Phenylketonuria mutations in Germany. Hum Genet 104(5):390–398
Zurflüh M, Zschocke J, Lindner M, Feillet F, Chery C, Burlina A, Stevens RC, Thöny B, Blau N (2008) Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Hum Mutat 29(1):167–175
Acknowledgments
The authors gratefully acknowledge the Foundation Program of the Jiangsu Province Department of Health (H201245) and the Science and Technology Support Program-Social Development of Science and Technology Bureau of Jiangsu Province (no. BE2012608) for their financial support.
Conflict of interest
The authors declare that they have no competing interests.
Ethical statement
This study was approved by the Institutional Review Board of Wuxi Maternal and Child Health Hospital. Written informed consent was obtained from all participants and, if younger than 18 years, their parents/guardians.
Authors’ contributions
Ya-fen Chen and Xin-ye Jiang conceived the study. Hai-tao Jia, Jing-jing Pei, Zhi-jun Wu, and Ya-li Qiu carried out sample and data acquisition and interpretation. Jia-ping Song, Jing Wang, Zhong-hai Chen, Gang Liu, and Dong-mei Sun analyzed the data and prepared the manuscript. Yu Liang provided intellectual input and helped in drafting the final manuscript. All authors provided intellectual contributions to the manuscript and has read and approved the final version.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Beat Steinmann
Revisions received: 18 March 2015/01 April 2015
Rights and permissions
About this article
Cite this article
Chen, Yf., Jia, Ht., Chen, Zh. et al. Mutational spectrum of phenylketonuria in Jiangsu province. Eur J Pediatr 174, 1333–1338 (2015). https://doi.org/10.1007/s00431-015-2539-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-015-2539-z